Ashurst advises on Welsh, Carson, Anderson & Stowe's £34m recommended offer for Abzena

Abzena provides specialist services and proprietary technologies to enable the selection, development and manufacturing of better biopharmaceuticals across its principal sites in Cambridge (UK), San Diego, California (USA) and Bristol, Pennsylvania (USA).

WCAS was founded in 1979, making it one of the oldest private equity firms in the world, and is the largest private equity investor focused exclusively on the healthcare and technology industries. Since its founding, WCAS has raised more than $22 billion across 16 partnerships and has invested approximately $9 billion in approximately 90 healthcare companies and funded hundreds of follow-on acquisitions. WCAS is currently investing out of WCAS XII, L.P., a $3.3 billion equity fund.

Peel Hunt is acting as financial adviser to WCAS in connection with the acquisition.

The Ashurst team is being led by partner Tom Mercer, assisted by associates Harry Thimont and Alli Clark.